Nick Maisey

1.7k total citations
16 papers, 796 citations indexed

About

Nick Maisey is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Nick Maisey has authored 16 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Nick Maisey's work include Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Esophageal and GI Pathology (3 papers). Nick Maisey is often cited by papers focused on Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Esophageal and GI Pathology (3 papers). Nick Maisey collaborates with scholars based in United Kingdom, Sweden and Australia. Nick Maisey's co-authors include Andrew Davies, James Gossage, David Cunningham, Janine Zylstra, Jesper Lagergren, Robert C. Mason, Elizabeth Smyth, William Allum, Fredrik Mattsson and Vicky Goh and has published in prestigious journals such as Journal of Clinical Oncology, British journal of surgery and European Journal of Cancer.

In The Last Decade

Nick Maisey

16 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Maisey United Kingdom 9 347 313 272 181 113 16 796
Kozo Miyatani Japan 15 328 0.9× 211 0.7× 282 1.0× 134 0.7× 82 0.7× 80 700
Kohei Wakatsuki Japan 19 546 1.6× 513 1.6× 526 1.9× 155 0.9× 155 1.4× 56 1.1k
Antonia Strippoli Italy 17 532 1.5× 328 1.0× 438 1.6× 236 1.3× 134 1.2× 66 1.1k
Takatoshi Fujishita Japan 13 554 1.6× 103 0.3× 370 1.4× 125 0.7× 99 0.9× 32 793
Tsunehiko Shigemori Japan 10 299 0.9× 157 0.5× 107 0.4× 120 0.7× 100 0.9× 16 549
Keun Wook Lee South Korea 14 499 1.4× 201 0.6× 299 1.1× 177 1.0× 90 0.8× 41 745
Naruo Tokuyasu Japan 17 388 1.1× 285 0.9× 286 1.1× 103 0.6× 253 2.2× 109 899
Shozo Ide Japan 19 432 1.2× 223 0.7× 180 0.7× 175 1.0× 349 3.1× 48 1.1k
Chengzeng Yin Japan 14 348 1.0× 128 0.4× 138 0.5× 116 0.6× 183 1.6× 28 653
Nobuhide Kubo Japan 13 186 0.5× 298 1.0× 181 0.7× 81 0.4× 128 1.1× 26 608

Countries citing papers authored by Nick Maisey

Since Specialization
Citations

This map shows the geographic impact of Nick Maisey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Maisey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Maisey more than expected).

Fields of papers citing papers by Nick Maisey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Maisey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Maisey. The network helps show where Nick Maisey may publish in the future.

Co-authorship network of co-authors of Nick Maisey

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Maisey. A scholar is included among the top collaborators of Nick Maisey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Maisey. Nick Maisey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Withey, Samuel J., Kasia Owczarczyk, Mariusz Grzeda, et al.. (2023). Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer. European Journal of Surgical Oncology. 49(10). 106934–106934. 1 indexed citations
2.
Moore, J., Greg Whyte, Janine Zylstra, et al.. (2023). Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the program. British journal of surgery. 110(12). 1668–1672. 2 indexed citations
3.
Zylstra, Janine, Greg Whyte, Kerri Beckmann, et al.. (2022). Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial. British Journal of Sports Medicine. 56(7). 402–409. 54 indexed citations
4.
Wulaningsih, Wahyu, D Foley, Dionysios Dellaportas, et al.. (2021). The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma. Journal of Surgical Oncology. 124(8). 1296–1305. 1 indexed citations
5.
Beckmann, Kerri, Janine Zylstra, Michelle Wilkinson, et al.. (2021). Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins. Acta Oncologica. 60(5). 672–680. 5 indexed citations
6.
Carroll, Robert, Dara Stein, Delphine Saragoussi, et al.. (2021). Nivolumab in Gastric/Gastroesophageal Junction Cancer: Real-World Data from UK Early Access to Medicines Scheme. Future Oncology. 17(24). 3163–3174. 3 indexed citations
7.
Davies, Andrew, James Gossage, Janine Zylstra, et al.. (2014). Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction. Journal of Clinical Oncology. 32(27). 2983–2990. 181 indexed citations
8.
Yip, Connie, Vicky Goh, Andrew Davies, et al.. (2014). Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. European Radiology. 24(5). 998–1005. 182 indexed citations
10.
Kendall, Anne, Rosemary Lord, & Nick Maisey. (2010). Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer. Recent Patents on Anti-Cancer Drug Discovery. 5(2). 142–151. 4 indexed citations
11.
Irshad, Sheeba & Nick Maisey. (2010). Considerations when choosing oral chemotherapy: identifying and responding to patient need. European Journal of Cancer Care. 19. 5–11. 21 indexed citations
12.
Maisey, Nick. (2007). Antitumor Necrosis Factor (TNF-a) Antibodies in the Treatment of Renal Cell Cancer. Cancer Investigation. 25(7). 589–593. 12 indexed citations
13.
Harrison, Michelle, Nick Maisey, Susan Hoare, et al.. (2007). Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose. Journal of Clinical Oncology. 25(29). 4542–4549. 195 indexed citations
14.
Maisey, Nick, Ian Chau, David Cunningham, et al.. (2002). Multicenter Randomized Phase III Trial Comparing Protracted Venous Infusion (PVI) Fluorouracil (5-FU) With PVI 5-FU Plus Mitomycin in Inoperable Pancreatic Cancer. Journal of Clinical Oncology. 20(14). 3130–3136. 101 indexed citations
15.
Maisey, Nick & David Cunningham. (2001). Current therapy and future prospects in lymphoma. Expert Review of Anticancer Therapy. 1(1). 29–41. 1 indexed citations
16.
Smith, Timothy, et al.. (2000). Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport.. PubMed. 41(10). 1753–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026